Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir/ritonavir interaction study with BMS-790052 in healthy volunteers
NL-OMON36726Active, not recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of daclatasvir, atazanavir and ritonavir in hepatitis C virus infection, sponsored by Bristol Myers Squibb. Primary endpoint: Pharmacokinetics. Started Mar 2011; status: active, not recruiting.
02
Drugs
daclatasviratazanavirritonavir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON36726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36726.